Citadel Advisors »

Casi Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Casi Pharmaceuticals (CASI) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Casi Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Casi Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Casi Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $146k 25k 5.96
2023-12-31 $120k 17k 7.27

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Casi Pharmaceuticals

VR Adviser
Wellington Shields Capital Management
Wellington Shields & Co
Renaissance Technologies
Woodline Partners
Citadel Advisors
Geode Capital Management
Royal Bank of Canada
Morgan Stanley
Wells Fargo & Company
BlackRock
BlackRock
Qube Research & Technologies
West Paces Advisors
Bank of America Corporation

View all funds holding Casi Pharmaceuticals